Skip to content
The Nexus
DossierENTITY

basal insulin

Coverage of basal insulin in the Nexus archive.

Earliest in view: Jul 6 · 16:45 UTCMost recent: Jul 6 · 16:45 UTC
Co-mentioned in this coverage
orforgliprontopic1Foundayotopic1ACHIEVE-5 trialtopic1American Diabetes Associationorganization1glycemic controltopic1body weighttopic1
Recent coverage
  • HEALTHJul 6 · 16:45 UTCMEDPAGE TODAY
    Oral GLP-1 Drug May Simplify Diabetes Treatment

    The ACHIEVE-5 trial demonstrated that adding oral orforglipron (Foundayo) to basal insulin improved glycemic control and reduced body weight in diabetes patients. The results were presented at the American Diabetes Association annual meeting.